SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment
Ontology highlight
ABSTRACT: Skin toxicity treatment in patients with advanced or metastatic colorectal cancer (mCRC) and non-mutated (wild-type) KRAS treated with panitumumab monotherapy after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.
DISEASE(S): Colorectal Carcinoma,Carcinoma,Colorectal Neoplasms
PROVIDER: 2111633 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA